Sai Pan

Attending Physician, Ph.D.

Department of Nephrology
PLA General Hospital, First Medical Center

About Me

I am an Attending Physician at the PLA General Hospital, specializing in nephrology with a focus on artificial intelligence applications in kidney disease diagnosis and prognosis.

My research integrates cutting-edge AI technologies with clinical nephrology, developing innovative multi-modal diagnostic systems for IgA nephropathy, diabetic nephropathy, and other kidney diseases. I lead multiple national-level research projects funded by NSFC and Beijing Natural Science Foundation.

As a recipient of the China Association for Science and Technology Young Elite Scientist Sponsorship Program (YESS), I am committed to advancing precision medicine through federated learning, pathomics, and deep learning approaches.

3
Active NSFC Projects
5+
First-Author Publications
5
Patents Filed
Cute squirrel

Education

2019 - 2023

Doctor of Philosophy (Ph.D.)

PLA General Hospital Graduate School

Major: Nephrology

2016 - 2019

Master of Medicine

PLA General Hospital Graduate School

Major: Nephrology

2011 - 2016

Bachelor of Medicine

Wuhan University

Major: Clinical Medicine

Research Projects

2026.01 - 2028.12

National Natural Science Foundation of China (NSFC) - Youth Project

Grant No. 82500943

Role: Principal Investigator | Funding: ¥300,000

Research on Federated Learning-Based Multi-modal Precision Diagnosis and Dynamic Prognosis Prediction System for IgA Nephropathy

2024 - Present

China Association for Science and Technology (CAST)

Young Elite Scientist Sponsorship Program (YESS)

Grant No.: YESS20240790 | Funding: ¥300,000

2024.01 - 2025.12

Beijing Natural Science Foundation - Youth Project

Grant No. 7244305

Role: Principal Investigator | Funding: ¥200,000

Research on IgA Nephropathy Diagnosis and Progression Risk Prediction Based on Pathomics and Multi-modal Data with Artificial Intelligence

2023 - Present

PLA General Hospital First Medical Center

Young Rising Star Talent Program

Funding: ¥150,000

Selected Publications

Representative publications demonstrating expertise in AI-driven nephrology, multi-modal medical imaging, and precision medicine

Co-first Author

A multimodal transformer system for noninvasive diabetic nephropathy diagnosis via retinal imaging

Dong Z, Wang X, Pan S*, Weng T, Chen X, et al. (*Co-first author)

npj Digital Medicine, 2025

Developed a novel transformer-based AI system that enables non-invasive diabetic nephropathy diagnosis through retinal imaging analysis, demonstrating the power of multi-modal approaches in precision medicine.

First Author

A multi-task deep sequential neural network for IgA nephropathy Oxford classification and prognosis prediction

Pan S, Fu Y, et al.

International Journal of Medical Informatics, 2025; 204:106052

Created an innovative multi-task deep learning framework for simultaneous Oxford classification and prognosis prediction in IgA nephropathy, advancing precision diagnostics in kidney disease.

Co-first Author

Multi-Task Learning-Based Immunofluorescence Classification of Kidney Disease

Pan S*, Fu Y*, Chen P, Liu J, Liu W, Wang X, et al. (*Co-first author)

International Journal of Environmental Research and Public Health, 2021; 18(20):10798

Pioneered multi-task learning approaches for automated immunofluorescence classification in kidney pathology, enabling more efficient and accurate diagnostic workflows.

First Author

Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients

Pan S, Zhao D, Li P, Sun X, Zhou J, et al.

Blood Purification, 2022; 51(2):171-181

Investigated critical relationships between ESA dosing, EPO resistance, and patient outcomes in hemodialysis populations, providing evidence for optimized treatment strategies.

First Author

Local hepcidin increased intracellular iron overload via the degradation of ferroportin in the kidney

Pan S, Qian Z, Cui S, Zhao D, Lan W, Wang X, Chen X

Biochemical and Biophysical Research Communications, 2020; 522(2):322-327

Elucidated the molecular mechanisms of iron metabolism in kidney tissue, demonstrating how local hepcidin regulates ferroportin degradation and contributes to iron overload pathophysiology.

Patents & Software

  • System and device for predicting diabetic nephropathy prognosis based on weighted quantile regression (CN 202411874049.X)
  • Renal function prediction method, device, equipment, medium and program product (CN 202310274193.9)
  • Multi-modal kidney pathology image processing method and device (CN 202410507490.8)
  • Method and system for predicting diabetic nephropathy based on fundus vascular geometric parameters (CN ZL202410281615.X)
  • National Blood Dialysis Quality Control Analysis Platform Software V1.0 (2019SR1192188)
  • National Peritoneal Dialysis Quality Control Analysis Platform Software V1.0 (2019SR1192189)

Contact

Let's Connect

I'm always open to discussing research collaborations, academic opportunities, and innovations in AI-driven nephrology.

🏥

Institution

PLA General Hospital, First Medical Center
Department of Nephrology

🔬

Research Interests

AI in Nephrology, Multi-modal Medical Imaging,
Precision Medicine, Federated Learning

📊

Funding

NSFC Youth Grant (¥300K)
CAST YESS Program (¥300K)
Beijing NSF (¥200K)